Market
Highlights:
Elastography
is a medical imaging method that plots the elastic properties of soft tissue to
stipulate the diagnostic data during surgery. The elastography imaging market
is fueled by numerous factors such as growing demand for minimally invasive
procedures to diagnose and treat different chronic diseases, along with the
rising prevalence of life-threatening diseases. However, the high cost of the
systems is expected to curb the growth of the elastography imaging market.
It is
estimated that the global Elastography
Imaging Market is expected to register a CAGR of 11.1% during the
forecast period of 2019 to 2025, with a market value of USD 2,538.2 million in 2018.
The global
elastography imaging market is currently dominated by numerous market players.
The key players are involved in new product launches and strategic
collaborations to strengthen its market position. For instance, in February
2019, Esaote launched the MyLabX8, an ultrasound platform to support hospitals
and clinics. Also, in November 2018, Canon Medical Systems Corporation
introduced Contrast Vector Imaging (CVI) to provide additional information on
liver hemodynamics and expand the use of contrast-enhanced ultrasound on its
premium ultrasound system.
Key Players:
·
Canon Medical Systems
Corporation
·
Siemens AG
·
Fujifilm Holdings
Corporation
·
Esaote, Resoundant Inc
·
Hitachi Ltd
·
Mindray Medical
International Ltd
·
Koninklijke Philips N.V
·
Samsung Electronics
(Samsung Medison)
·
Supersonic Imagine
Segmentation:
·
The global elastography imaging market
has been segmented based on modality, application, and end user.
·
The market, based on modality, has been
bifurcated into ultrasound, and magnetic resonance elastography. The ultrasound
segment is expected to hold a major share in the market, owing to the high advantages
of this type of modality. The magnetic resonance elastography segment is
anticipated to be the fastest growing due to the wider availability and rising
adoption rate.
·
The market, by application, has been
divided into radiology/general imaging, cardiology, obstetrics/gynecology,
urology, vascular, orthopedic & musculoskeletal applications, and others.
·
The market, by end user, has been
classified as hospitals & ambulatory surgical centers, diagnostic centers,
research laboratories, and others.
Regional
Analysis:
The market in
the Americas is likely to lead the global elastography imaging market during
the assessment period owing to the increasing per capita healthcare expenditure, and the heavy
adoption of new technology in the region. Additionally, the
increase in the insurance coverage and improving reimbursement scenario in the
US and Canada are also projected to drive the growth of the market.
Europe is
expected to hold the second largest position in the global elastography imaging
market. The market growth in this region is because of the presence of a
well-established healthcare system, an increase in life-threatening diseases,
and the active involvement of major players. For instance, in May 2017, Esaote
expanded its ultrasound sales team in the UK.
The market in
Asia-Pacific is projected to have a steady growth rate during the forecast
period owing to the increasing number of patients with chronic diseases and
government initiatives for healthcare reforms. However, a decrease in capital
investment is restricting the market growth of this region.
No comments:
Post a Comment